MoneyWorks4Me

FDC receives USFDA’s approval for Dorzolamide and Timolol Ophthalmic Solution

17 Jun 2019 Evaluate

FDC has been granted ANDA approval by United States Food and Drug Administration (USFDA), for Dorzolamide and Timolol Ophthalmic Solution USP 22.3mg/6.83mg per ml, a generic version of Cosopt of Oak Pharmaceuticals Inc.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..